Factors influencing reduced effectiveness of intermediate processes in the delivery of IPTp-SP, IPTp-SP by DOT and ITNs (in the presence of required stock).

<p>Notes:</p><p>SP, Sulfadoxine-pyrimethamine; ITN, Insecticide Treated Net; CSCom, Community health center; CSRef, Reference health center; ANC, Antenatal Clinic; DOT, Direct Observed Treatment; IPTp, Intermittent Preventive Treatment; SES, Socio-economic Status; CFA, Franc XOF;</p><p>↑, arrow indicating high level; ↓, arrow indicating low level.</p

Diagnosis categories for ineffective implementation of the delivery of IPTp-SP and ITNs based upon quotes of health workers.

<p>Diagnosis categories for ineffective implementation of the delivery of IPTp-SP and ITNs based upon quotes of health workers.</p

Factors reducing the effectiveness for pregnant women of receiving any IPTp-SP by DOT when of eligible gestation during an ANC visit.

<p>Note: SP, sulfadoxine-pyrimethamine; ANC, antenatal clinic; DOT, directly observed treatment; IPTp, intermittent preventive treatment.</p

Cumulative effectiveness of delivery of IPTp during 1^st ANC visit by women 4 to 8 months pregnant.

<p>Intermediate process 1 = attend ANC consultation; Intermediate process 2 = given SP during ANC consultation; Intermediate process 3 = given 3 tablets SP; Intermediate process 4 = take SP by DOT (A); or take SP by DOT or have 3 tablets on exit and can report correctly how they will be taken (B).</p

Unadjusted and adjusted predictors of being offered an ITN in the CSComs.

<p>Notes:</p><p>n, number of events; OR, Odds Ratio, CI, Confidence Interval; SES, Socio-economic Status; ANC, Antenatal Clinic; HIV, Human Immunodeficiency Virus; PMTCT, Prevention of Mother to Child Transmission.</p

Unadjusted and adjusted predictors of being given SP by DOT amongst those who were given IPTp-SP in consultation at CSComs.

<p>Notes:</p><p>SP, Sulphadoxine-pyrimethamine; DOT, Direct Observed Treatment; n, number of events; OR, Odds Ratio, CI, Confidence Interval; SES, Socio-economic Status; Na, not available.</p

Cumulative and intermediate process effectiveness of delivery of ITNs amongst pregnant women of any gestation.

<p>Notes:</p><p>CSRef, Reference Health Centre; CSCom, Community Health Centre; n, number of events; CI, Confidence Interval; ANC, Antenatal Clinic; ITN, Insecticide Treated Net.</p><p>Intermed = Intermediate process effectiveness; Cum = cumulative effectiveness.</p

Characteristics of pregnant women attending the CSRef and the CSComs.

<p>Notes:</p><p>Primary+ = any level above primary (secondary, tertiary etc).</p><p>CSRef, Reference Health Centre; CSCom, Community Health Centre; n, number of events; N, sample size; ANC, Antenatal clinic;</p

Cumulative effectiveness of delivery of ITNs during 1^st ANC visit by women of any gestation.

<p>Intermediate process 1 = attend ANC; Intermediate process 2 = offered ITN during ANC consultation; Intermediate process 3 = take ITN.</p

Cumulative and intermediate process effectiveness of delivery of IPTp-SP amongst those 4 to 8 months pregnant.

<p>Notes:</p><p>CSRef, Reference Health Centre; CSCom, Community Health Centre; n, number of events; CI, Confidence Interval; Cum, cumulative process; Intermed, Intermediate process; DOT, Direct Observed Treatment; ANC, Antenatal Clinic; SP, Sulphadoxine-pyrimethamine.</p